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A B S T R A C T
Patients with Parkinson’s disease (PD) are more susceptible to muscle fatigue, which can damage their
gait. Physical activity can improve muscle condition, which is an important aspect during walking. The
aim of this study was to analyze the effects of lower limb muscle fatigue on gait in patients with PD and
healthy individuals, grouped according to physical activity level. Twenty Patients with PD (PD group)
and 20 matched individuals (control group) were distributed according to physical activity level into
four subgroups of ten individuals (active and inactive). Participants performed three walking trials
before and after lower limb muscle fatigue, induced by a repeated sit-to-stand task on a chair. Kinematic
(stride length, width, duration, velocity and percentage of time in double support) and kinetic
(propulsive and breaking anterior–posterior and medio-lateral impulse) gait parameters were analyzed.
In both groups, participants increased stride length and velocity and decreased stride duration and
braking vertical impulse after lower limb muscle fatigue. The PD groups presented higher step width and
percentage of double time support than the control groups before muscle fatigue. The control groups
increased step width and decreased percentage of time in double support, while the PD groups did not
change these parameters. For physical activity level, active individuals presented longer stride length,
greater stride velocity, higher braking and propulsive anterior–posterior impulse and shorter step width
than inactive individuals. Groups sought more balance and safety after lower limb muscle fatigue.
Physical activity level does not appear to modify the effects of lower limb muscle fatigue during
unobstructed walking in individuals with PD or controls.
 2016 Published by Elsevier B.V.
Contents lists available at ScienceDirect
Gait & Posture
jo u rn al h om ep age: ww w.els evier .c o m/lo c ate /g ai tp os t1. Introduction
The general increase in human life expectancy coincides with
an increase in the number of people with chronic diseases, such as
Parkinson’s disease (PD). Patients with PD present several motor
and non-motor impairments [1], including a higher perception of
fatigue than age-matched controls [2]. The exacerbated perception
of fatigue is caused by musculoskeletal and neurophysiological
impairments associated with PD, particularly resulting from
altered norepinephrine and serotonin production due to degener-
ation of neurons of the raphe nuclei and locus coeruleus* Corresponding author at: Posture and Gait Studies Lab, Department of Physical
Education, UNESP, Univ Estadual Paulista at Rio Claro, Avenida 24-A, 1515,
Bela Vista, Rio Claro/São Paulo, Brazil. Tel.: +55 19 981715558.
E-mail address: paulocezarr@hotmail.com (P.C.R. Santos).
http://dx.doi.org/10.1016/j.gaitpost.2016.04.002
0966-6362/ 2016 Published by Elsevier B.V.[1,3]. However, little is known about the effects of fatigue on
movement in patients with PD. Previous studies indicate that gait
is affected by fatigue in an age-dependent manner [4]. Gait
adjustments with muscle fatigue are more pronounced in
individuals over 40 years of age than in younger individuals.
These adjustments appear to be aimed at maintaining adequate
control of balance in the fatigued condition [4]. It is conceivable
that individuals with PD demonstrate even more pronounced gait
adjustments, since patients with PD present deficits in muscle
strength and motor control [5].
Muscle fatigue could be expected to affect gait less in
individuals with higher physical activity levels, due to their better
neuromuscular and cardiovascular condition [6], which influences
the process of muscle fatigue development [7]. However, the
effects of muscle fatigue on gait in young adults are not dependent
on their physical activity level [8]. This might be due to young
adults having substantial remaining capacity to deal with the
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substantial muscle fatigue. Thus, whether this is generalized to
older and diseased populations is unknown. Regular physical
activity improves functional capacity [9] and walking ability [10]
in patients with PD and likely slows down fatigue development,
but whether it improves their gait in a fatigued state is unknown.
Therefore, the aim of the present study was to analyze the
effects of lower limb muscle fatigue on gait in patients with PD and
in healthy individuals, grouped according to physical activity level.
We expected that patients with PD would be more affected by
lower limb muscle fatigue than healthy controls. In addition, we
hypothesized that both groups would improve anterior–posterior
and medio-lateral balance control after lower limb muscle fatigue.
Furthermore, we hypothesized that there would be an interaction
between lower limb muscle fatigue and physical activity level,
with greater effects of muscle fatigue on gait parameters in
inactive participants of both groups.
2. Methods
2.1. Participants
After signing the informed consent, forty subjects participated
in the study which had been approved by the local ethics
committee (#3083/2011); 20 individuals with PD (PD group),
according to the UK Brain Bank Criteria [11], and 20 neurologically
healthy matched-individuals (control group). Individuals were
included if they met the following inclusion criteria: (i) indepen-
dently living in the community, able to walk without the use of any
aids, not presenting balance or vision disorders (to guarantee no
interference from individual disorders, walking limitations or
safety during walking); (ii) did not have diabetes, hypertension,
cardio-respiratory diseases. In addition, for patients with PD, the
individuals were included in the study if the stage in Hoehn & Yahr
Scale (H&Y) [12] was 3. During the sample selection process,
19 patients with PD and 4 neurologically healthy individuals were
initially recruited but did not fit the criteria of the study.
Within the groups, two sub-groups (n = 10) were formed,
according to physical activity level (active and inactive group).
The Modified Baecke Questionnaire for Older Adults (MBQOA) [13]
was used to determine the physical activity level. The active group
was composed of individuals who scored 5 on the questionnaire
and the inactive group was composed of individuals who scored 4
[14]. The PD group and the control group were matched by gender,
age, body height and body mass and these parameters were similar
in the sub-groups. The PD sub-groups were matched according to
the PD stages and the clinical characteristics. A neuropsychiatrist
performed a clinical assessment of the patients with PD to determine
the stage of the disease in each patient and to test them on the motor
section of the Unified Parkinson’s Disease Rating Scale (UPDRS) [15],
H&Y [12] and Mini-Mental State Examination (MMSE) [16].
2.2. Maximum voluntary contraction protocol
Maximum voluntary isometric contractions were performed on
a leg press device [4,9]. A load cell with a precision of 0.98 N was
used in combination with a signal amplifier (EMG System do Brasil
Ltda.). The participants performed the test using both lower limbs
simultaneously (hip joint angle = 1108 and knee joint angle = 908
with 1808 as full extension) and were instructed to produce
maximum force as fast as possible for 5 s. Two attempts were
performed before and after lower limb muscle fatigue, with a 2 min
rest between attempts. The means of the two attempts before and
after muscle fatigue were calculated for each participant. The
maximum voluntary contraction was used to confirm the presence
of muscle fatigue [4,8].2.3. Lower limb muscle fatigue protocol
To induce lower limb muscle fatigue, participants performed a
repeated sit-to-stand task from a chair with arms across the chest
region [4,8]. The frequency of the sit-to-stand movement was
controlled by a metronome (30 cycles/min). A standard chair
(43 cm in height, 41 cm in width and 42 cm in depth) without
armrests was used for all participants. The instructions given to the
participants were: stand up in an upright position with knees fully
extended, then sit back down and repeat the task at the beat of the
metronome until you can no longer perform the task. The fatigue
protocol was stopped when one of the following conditions was
met; the participant indicated their inability to continue, the
movement frequency fell below and remained below 30 cycles/
min after encouragement, or after 30 min. The time to fatigue was
recorded. The gait task and subsequently the maximal voluntary
protocol were repeated immediately after the fatigue protocol.
2.4. Gait task
Participants performed three trials of unobstructed gait before
and after the lower limb muscle fatigue protocol. Participants
received the instruction to walk over an 8 m wooden pathway,
which was covered with a black rubber carpet (3 mm thick), at a
self-selected speed. The gait parameters of the stride (period
between two consecutive heel contacts of the right limb) in the
middle of the pathway were analyzed in the study.
2.5. Data analysis
Acquisition of kinematic gait parameters was accomplished
with a three-dimensional optoelectronic system (OPTOTRAK
Certus – 3D Motion Measurement System – Northeim Digital –
NDI, Waterloo, Ontario, Canada), positioned in the right sagittal
plane, using a sampling rate of 100 samples/s. Infrared emitters
were placed over the lateral aspect of the calcaneus and the head of
the fifth metatarsus of the right limb, and over the medial aspect of
the calcaneus and the head of the first metatarsus of the left limb.
Data were filtered using a 5th order low-pass digital Butterworth
filter (zero-lag) with a cutoff frequency of 6 Hz. Stride length, stride
duration, stride velocity, percentage of time in double support and
step width were calculated.
Ground reaction forces were measured using a force plate
(AccuGait, Advanced Mechanical Technologies) with a sampling
frequency of 200 Hz, synchronized with the Optotrak system. The
force plate was positioned across the central area of the pathway. The
kinetic data were filtered using a 4th order low-pass digital
Butterworth filter (zero-lag) with a cutoff frequency of 16 Hz. The
magnitude of the ground reaction force was normalized by body
weight from an acquisition in the orthostatic position and braking and
propulsive vertical and anterior–posterior impulses were calculated.
2.6. Statistical analysis
The analysis with G*Power software showed that a sample size
of at least 32 individuals (8 in each group) was needed for an 80%
probability to detect a difference of 20% between the two groups
for the primary outcome (stride velocity) with a type I error of 0.05,
based on previously published data [4]. The statistical analyses
were performed with SPSS 18.0 for Windows1. The level of
significance was set at 5% for all analyses. Physical activity level
was compared between the PD and control groups using one-way
ANOVA. Time to fatigue was compared between the four sub-
groups using a two-way ANOVA, with group and physical activity
level (active and inactive sub-groups) as factors. The gait
parameters and maximum voluntary isometric contractions were
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fatigue (before and after lower limb muscle fatigue) as factors, with
repeated measures over the last factor. When the MANOVA




The characteristics of each group, score in physical activity level
and time to fatigue of the lower limb muscles are presented in
Table 1. There was no difference between the PD and control
groups for physical activity level (active: p < 0.90 and inactive:
p < 0.61). For the time to fatigue of the lower limb muscles, the
ANOVA indicated main effects of group (F1,36 = 17.34, p < 0.001)
and physical activity level (F1,36 = 14.48, p < 0.001), and an
interaction between group and physical activity level
(F1,36 = 9.94, p < 0.003). The control group showed a longer time
to fatigue than the PD group (p < 0.001), the active group showed a
longer time to fatigue that the inactive group (p < 0.001) and the
interaction indicated a much longer time to fatigue in the active
control group than in all the other groups (p < 0.001).
3.2. Maximum voluntary contraction protocol
Regarding maximum voluntary isometric contractions
(Table 2), the MANOVA indicated main effects of group
(F1,36 = 12.10, p < 0.001) and fatigue (F1,36 = 10.13, p < 0.003),
but no effects of physical activity level (F1,36 = 0.05, p = 0.81) and
no interactions between factors (F1,36 = 0.14, p = 0.71). For group,
the univariate analyses indicated that the PD group had a lower
maximum voluntary isometric contraction than the control group.
For fatigue, there was a reduction in the maximum voluntary
isometric contraction after the fatigue protocol when compared to
before. It is important to highlight that all individuals decreased
the value of maximum voluntary isometric contraction after lower
limb muscle fatigue.Table 1
Means and standard deviations of height, body weight, age, physical activity level
score and time to fatigue for the quadriceps muscles for the active and inactive PD
groups and the control group. In addition, means and standard deviations of clinical
characteristics of the active and inactive PD groups.
Characteristics of the participants and time to muscle fatigue
Parameters PD group Control group
Active Inactive Active Inactive
Height (cm) 165.5  8.8 166.5  5.8 165.2  7.3 170.6  6.9
Body
weight (kg)
72.6  7.6 73.1  10.1 68.6  9.4 78.7  12.8








107.6  39.5 80.8  21.3 408.6  234.5 122.3  133.2
H&Y (score) 2.0  0.2 1.8  0.2
UPDRS III
(score)
31.8  6.9 29.1  6.7
MMSE (score) 28.7  1.6 29.1  1.5
PD, Parkinson’s disease; H&Y, Hoehn and Yahr Scale; UPDRS, Unified Parkinson
Disease Rating Scale.3.3. Gait parameters
For the kinematic gait parameters (Table 2), there were main
effectsof group (Wilks’ Lambda = 0.63, F5,32 = 3.70, p < 0.009), fatigue
(Lambda = 0.44, F5,32 = 8.02, p < 0.001) and physical activity level
(Wilks’ Lambda = 0.65, F5,32 = 3.51, p < 0.006) and an interaction
between group and fatigue (Wilks’ Lambda = 0.62, F5,32 = 3.97,
p < 0.006), but no interactions between physical activity level and
any other parameters. For group, the univariate analyses indicated
shorter stride length (F1,36 = 8.77, p < 0.006), percentage of time in
double support (F1,36 = 4.16, p < 0.04) and stride duration
(F1,36 = 4.42, p < 0.04) and larger step width (F1,36 = 4.48, p < 0.04)
for the PD group. For fatigue, individuals increased stride length
(F1,36 = 20.91, p < 0.001) and speed (F1,36 = 19.71, p < 0.001) and
decreased stride duration (F1,36 = 10.92, p < 0.002) and braking
vertical impulse (F1,36 = 2.56, p < 0.02) after lower limb muscle
fatigue. For physical activity level, active individuals demonstrated
longer stride length (F1,36 = 7.70, p < 0.009), greater stride velocity
(F1,36 = 5.52, p < 0.02), higher braking (F1,36 = 4.51, p < 0.04) and
propulsive anterior–posterior impulse (F1,36 = 7.72, p < 0.009) and
shorter step width (F1,36 = 5.82, p < 0.02) than inactive individuals.
Concerning the interaction between fatigue and group for gait
parameters (Fig. 1), the analyses indicated significant differences
for step width (F1,36 = 4.51, p < 0.04) and percentage of time in
double support (F1,36 = 7.28, p < 0.01). The post hoc analyses
identified that, before lower limb muscle fatigue, the PD group
showed greater step width and a higher percentage of time in
double support than the control group (p = 0.02). However, after
muscle fatigue, the control group increased step width (p = 0.04)
and decreased the percentage of time in double support
(p = 0.005), while the PD group did not change these parameters
(p = 0.32 and p = 0.19, respectively). As a result, after lower limb
muscle fatigue, there was no difference in step width between the
groups (p = 0.27), while the healthy controls presented a shorter
double support time (p = 0.02) than the PD group.
4. Discussion
The aim of this study was to analyze the effects of lower limb
muscle fatigue on gait in patients with PD and neurologically
healthy individuals according to their physical activity level. Lower
limb muscle fatigue caused adjustments in gait parameters in both
the PD and control groups, which was in agreement in part with
our hypothesis. However, in contrast with our expectations, the PD
group did not demonstrate stronger effects of lower limb muscle
fatigue; instead the gait changes were generally more pronounced
in the healthy control group, even though the PD group had lower
maximum voluntary isometric contraction strength. In contrast
with our third hypothesis, we did not find interactions between
physical activity level and lower limb muscle fatigue in gait
parameters. Active and inactive individuals from both groups
presented similar walking behavior after lower limb muscle
fatigue. Active control individuals demonstrated longer time to
fatigue of the lower limb muscles in comparison with the other
groups. In the following paragraphs, we will discuss interpreta-
tions of the gait changes observed and explanations for the
unexpected direction of the interaction between fatigue and PD,
with larger fatigue-related changes in the control group compared
to the PD group, as well as for the lack of interaction between
physical activity level and fatigue.
Both PD and healthy subjects presented fatigue-related gait
changes, which is consistent with an attempt to enhance the
control of balance in the anterior–posterior direction. Similar
changes in spatial–temporal gait parameters have been shown
previously after gait perturbation, such as muscle fatigue [4,8]. An
increase in stride length and a decrease in stride duration may
Table 2
Means and standard deviation for gait parameters of the active and inactive PD group and control group pre and post muscle fatigue. The last three columns show the p-values
for main effects of group, fatigue and physical activity level, respectively.
PD group Control group Main effects (p-value)




Active 1785.56  559.58 1592.89  403.67 2576.03  623.67 2445.98  553.50 0.001 0.003 0.812
Inactive 1762.04  461.0 1696.48  575.26 2402.67  1026.75 2293.98  885.63
Stride length (cm) Active 124.69  10.69 127.96  12.19 132.28  10.69 135.96  12.61 0.006 0.001 0.009
Inactive 107.57  15.21 110.43  14.67 123.27  14.93 130.74  20.41
Step width (cm) Active 11.61  2.44 11.33  2.21 10.18  2.77 11.52  2.90 0.04 0.38 0.02
Inactive 14.88  5.32 14.14  1.99 11.13  1.34 12.29  2.20
Percentage of time in
double support (%)
Active 29.85  2.23 28.94  1.69 32.45  3.88 26.02  1.45 0.04 0.14 0.11
Inactive 35.81  8.20 39.31  12.81 29.85  2.26 27.11  3.77
Stride duration (s) Active 0.99  0.11 0.98  0.10 1.11  0.08 1.06  0.12 0.04 0.002 0.27
Inactive 1.09  0.09 1.02  0.13 1.10  0.12 1.06  0.06
Stride velocity (cm/s) Active 122.17  17.55 132.26  22.85 119.75  14.15 130.65  19.05 0.43 0.001 0.02
Inactive 99.57  18.53 110.89  20.32 113.37  20.87 119.13  26.45
Braking vertical
impulse (%BW/ms)
Active 0.27  0.02 0.27  0.05 0.29  0.03 0.28  0.03 0.76 0.02 0.14
Inactive 0.32  0.05 0.29  0.05 0.28  0.03 0.28  0.04
Propulsive vertical
impulse (%BW/ms)
Active 0.24  0.04 0.24  0.04 0.28  0.03 0.26  0.03 0.73 0.18 0.56
Inactive 0.27  0.05 0.28  0.05 0.26  0.05 0.25  0.05
Braking anterior–posterior
impulse (%BW/ms)
Active 0.026  0.005 0.027  0.006 0.029  0.005 0.032  0.003 0.08 0.53 0.04
Inactive 0.024  0.008 0.023  0.005 0.027  0.008 0.025  0.004
Propulsive anterior–posterior
impulse (%BW/ms)
Active 0.026  0.007 0.027  0.005 0.032  0.003 0.031  0.004 0.35 0.09 0.009
Inactive 0.024  0.003 0.025  0.005 0.025  0.004 0.026  0.005
MF, muscle fatigue; PD, Parkinson’s disease; BW, body weight.
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the cost of increasing the risk of falling backward [19]. An
increase in stride length (3 cm) is clinically relevant for
patients with PD; a small increase in stride length was observed
in previous studies [4,8]. First, longer strides require more
muscle activation, which could be a problem due to weakness in
this population [5]. Second, any increase in stride length, even
small, can enhance balance control in the sagittal plane. In
walking, the anterior margin of safety is negative, which could
cause a forward fall [20]. An increase in stride length may
decrease the magnitude of the negative margin and, conse-
quently, the risk of forward falls [21]. Therefore, under the
fatigued muscle condition, small adjustments are clinically
important to avoid falls during gait.
The combination of modulation in stride length and stride
duration causes an increase in walking speed, which may in fact
lead to more stable gait [21]. Alternatively, the increase in walking
speed with lower limb muscle fatigue may be a strategy to cover
the short distance walked in this study in as little time as possible
[4,8]. However, higher walking speed decreases the time availableFig. 1. Interaction between group and fatigue for step width and percentage of time in dou
control group (gray line). MF, muscle fatigue; PD, Parkinson’s disease. #Difference betwe
group.to acquire information and to integrate sensory information [22],
which may increase the risk of falling, especially in patients with
PD who have an impaired sensory integration capacity [23]. This
might lessen the pronounced changes observed in the PD group.
Gait changes observed also have consequences for balance in the
medio-lateral direction; healthy subjects enlarged their base of
support by increasing step width, which did not occur in the PD
group. The lack of change in step width of the PD group may
suggest a robust system in patients with PD due to the difficulty in
performing an adjustment – stiffness strategy [22]. Furthermore,
patients with PD present a degradation in sensorimotor integration
and sensory feedback [25,26], which may be associated with
deficits in perception of fatigue [2,24] and consequently gait
adjustments to improve safety. Another alternative explanation for
the less pronounced changes in patients with PD may be that the
central activation of their muscles in the fatigue protocol was
insufficient to cause muscle overload and induce metabolic fatigue
[5]. However, the task was standardized and no interaction effect
of group and fatigue was found on the maximum voluntary
isometric contraction force.ble support before and after quadriceps muscle fatigue for PD group (black line) and
en before and after quadriceps muscle fatigue. *Difference between PD and control
P.C.R. Santos et al. / Gait & Posture 47 (2016) 86–9190Physical activity level did have a main effect on gait
parameters, indicating a more vigorous and ‘healthy’ gait
pattern in the more active sub-groups. Physical activity
improves muscle condition [24] and the negative perception
of fatigue [26], which may underlie the differences in gait
between the active and inactive sub-groups. For the active PD
group, these effects may be important, as they would counteract
bradicinesia and hypometria [10]. However, given the cross-
sectional nature we cannot establish the direction of the
causality. Importantly, the physical activity level did not interact
with lower limb muscle fatigue. This may be because the gait
task in this study did not pose large demand on the locomotor
system, while more complex tasks, such as obstacle crossing
during walking [27], might reveal such interactions, especially
for patients with PD, who experience more difficulty with
obstacle crossing [23].
Although the results of this study are consistent and relevant,
this study has certain limitations that should be addressed: (i) the
lack of a group which was not induced to muscle fatigue, but
performed the same protocol without muscle fatigue was a
limitation of the study. The lack of inclusion of a control group may
hinder some statements about if the changes occur due to the
fatigue protocol or another uncontrolled factor (i.e., the time
duration of experimental procedures or learning effect). However,
similar results were found in different populations [4,5,8] and
environments [28], even after 20 min of rest [29], which seems to
indicate consistent results regarding the effects of muscle fatigue
on gait parameters; (ii) the task to induce lower limb muscle
fatigue was the sit-to-stand task, which requires substantial
activity of the quadriceps femoris muscles but also of other lower
limb muscles. Patients with PD present muscle weakness and an
exacerbated perception of fatigue [6], which may decrease the
time in the muscle fatigue protocol and limit muscle fatigue
induction in this group. However, the maximum voluntary
isometric contraction, the indicator of muscle fatigue [4,8],
decreased as much in the PD group as in the healthy group;
(iii) the muscle fatigue protocol could be made more specific for
walking, for example, walking until exhaustion. While this would
improve the ecological validity, the time to induce muscle fatigue
would increase considerably and this might interfere with time-
dependent effects of medication in the PD group [30]; (iv) the
MBQOA, used to divide the participants into active and inactive
sub-groups, does not evaluate all potentially relevant tasks (such
as occupational tasks) and may not discriminate physical activity
levels adequately; (v) we used a relatively small sample of
participants. Considering these limitations, generalization should
be performed with care.
We concluded that lower limb muscle fatigue affects the gait
parameters of patients with PD and neurologically healthy
matched-individuals. Both groups demonstrated gait changes
that could be interpreted as seeking to improve balance and
safety after lower limb muscle fatigue. However, these adjust-
ments were less pronounced in patients with PD. Moreover,
physical activity level did not affect the gait changes occurring
after lower limb muscle fatigue, either in patients with PD or in
healthy individuals. The findings of this study add to the
knowledge about walking in patients with PD, especially related
to physical activity and muscle fatigue. Physical activity is an
important aspect to improve gait in patients with PD, counter-
acting the advance of the disease, although having no interaction
with lower limb muscle fatigue. However, clinically, patients
with PD presented a robust system, which was characterized by
difficulty in performing adjustments after lower limb muscle
fatigue. Thus, our results can help in developing strategies
dealing with the effects of lower limb muscle fatigue on gait
parameters in patients with PD.Conflict of interest statement
None declared.
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fatigue and physical activity level in motor control of the gait of young adults.
Gait Posture 2013;38(4):702–7.
[9] Orcioli-Silva D, Simieli L, Barbieri FA, Rinaldi NM, Vitório R, Gobbi LTB. Effects
of a multimodal exercise program on the functional capacity of Parkinson
disease patients considering disease severity and gender. Motriz. Rev. Ed. Fis.
2014;20:1–4.
[10] Vitório R, Lirani-Silva E, Barbieri FA, et al. Effects of 6-month, multimodal
exercise program on clinical and gait parameters of patients with idiopathic
Parkinson’s disease: a pilot study. ISRN Neurol. 2011;1–7.
[11] Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of
idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J.
Neurol. Neurosurg. Psychiatry 1992;55:181–4.
[12] Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neu-
rology 1967;17:427–42.
[13] Voorrips LE, Ravelli AC, Dongelmans PC, Deurenberg P, Van Staveren WA. A
physical activity questionnaire for the elderly. Med. Sci. Sports Exerc.
1991;23(8):974–9.
[14] Nascimento CMC, Gobbi S, Hirayama MS, Brazão MC. Nı́vel de atividade fı́sica e
as principais barreiras percebidas por idosos de Rio Claro. REVDEF
2008;19(1):109–18.
[15] Fahn S, Elton R, Members of the UPDRS Development Committee. The unified
Parkinson’s disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein
M, editors. Recent Developments in Parkinson’s Disease, vol. 2. Florham Park,
NJ: McMellam Health Care Information; 1987. p. 153–63.
[16] Brucki SMD, Nitrini R, Caramelli P, Bertolucci PHF, Okamoto IH. Sugestões para
o uso do mini-exame do estado mental no Brasil. Arq. Neuropsiquiatr.
2003;61(3-B):777–81.
[17] Hof AL, Gazendam MG, Sinke WE. The condition for dynamic stability. J.
Biomech. 2005;38:1–8.
[18] Hof AL, van Bockel RM, Schoppen T, Postema K. Control of lateral balance in
walking: experimental findings in normal subjects and above-knee amputees.
Gait Posture 2007;25:250–8.
[19] Hak L, Houdijk H, Steenbrink F, et al. Speeding up or slowing down? Gait
adaptations to preserve gait stability in response to balance perturbations.
Gait Posture 2012;36:260–4.
[20] Carpenter MG, Allum JHJ, Honegger F, Adkin AL, Bloem BR. Postural abnor-
malities to multidirectional stance in Parkinson’s disease. J. Neurol. Neurosurg.
Psychiatry 2004;75:1245–54.
[21] Bruijn SM, van Dieen JH, Meijer OG, Beek PJ. Is slow walking more stable? J.
Biomech. 2009;42:1506–12.
[22] Lewis GN, Byblow WD. Altered sensorimotor integration in Parkinson’s dis-
ease. Brain 2002;125(9):2089–99.
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